OraSure Technologies to Present at the 37th Annual J.P.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
35
OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference

BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 37 TH Annual J.P. Morgan Healthcare Conference.  The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on January 10, 2019, at approximately 7:30 AM Pacific Time (10:30 PM Eastern Time).  Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link.  A replay of the webcast will be available on OraSure Technologies’ web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link: https://jpmorgan.metameetings.net/events/heal...nc/webcast                              

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick ® platform, oral fluid sample collection, and stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.  For more information on OraSure Technologies, please visit www.orasure.com .

Company contact:

Roberto Cuca Jeanne Mell
Chief Financial Officer VP Corporate Communications
610-882-1820 484-353-1575
Investorinfo@orasure.com media@orasure.com
www.orasure.com www.orasure.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

A100x Unveils New Fund to Empower AI and Blockchain Startups

Updated Category News Views 296

A100x Launches $50 Million Fund II to Support Innovative Startups With a mission to empower early-stage companies in the domains of artificial intelligence (AI), digital assets, and blockchain technology, A100x has proudly announced its new $50 million fund. This initiative showcases A100x's commitment to fostering the next generation of innovators, building applications...

Continue Reading
Clover Health's Dr. Ian Duncan Elected SOA President-Elect

Updated Category News Views 168

Clover Health Celebrates Dr. Ian Duncan's SOA Election Clover Health, a pioneering physician enablement company, expresses its excitement over the recent election of Dr. Ian Duncan as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries (SOA). This significant announcement was made on September 12, 2025, at the SOA ImpACT Annual Conference....

Continue Reading
Stellar Cyber and LastPass Team Up for Next-Level Credential Security

Updated Category News Views 130

Revolutionizing Credential Security: Stellar Cyber and LastPass In a significant advancement for cybersecurity, Stellar Cyber and LastPass have joined forces to offer a pioneering integration that elevates credential protection to new heights. This collaboration combines Stellar Cyber’s innovative threat detection technology with the robust credential management...

Continue Reading
Quarterly Financial Results of CCA Industries, Inc. Revealed

Updated Category News Views 84

Overview of CCA Industries, Inc. Financial Performance CCA Industries, Inc. (OTC: CAWW) has recently released its financial results for the quarter and nine-month period. The findings from these reports highlight noteworthy shifts in both revenue and strategic operations. Recent Financial Results The company reported a net loss of $444,878 for the third quarter....

Continue Reading
Meritage Homes Reports Strong Q3 2024 Performance Metrics

Updated Category News Views 222

Meritage Homes Achieves Impressive Growth in Third Quarter 2024 Meritage Homes Corporation (NYSE: MTH), a leading homebuilder, disclosed its third quarter performance results, which marked a significant achievement for the company. The data reflects the period ending in September 2024, showing robust growth and positive shifts in business strategy. Notable Operating...

Continue Reading